Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ECTE [NASD]
Echo Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.31 Insider Own0.79% Shs Outstand60.24M Perf Week17.02%
Market Cap33.13M Forward P/E- EPS next Y-0.34 Insider Trans26.60% Shs Float53.54M Perf Month-11.29%
Income-12.33M PEG- EPS next Q-0.09 Inst Own7.11% Short Float0.89% Perf Quarter-23.61%
Sales0.01M P/S3313.20 EPS this Y36.28% Inst Trans41.68% Short Ratio2.10 Perf Half Y-59.85%
Book/sh0.27 P/B2.04 EPS next Y5.60% ROA-62.36% Target Price2.92 Perf Year-67.65%
Cash/sh0.06 P/C8.84 EPS next 5Y40.00% ROE-90.88% 52W Range0.18 - 2.00 Perf YTD-47.12%
Dividend- P/FCF- EPS past 5Y0.00% ROI-89.76% 52W High-71.20% Beta0.43
Dividend %- Quick Ratio- Sales past 5Y-38.46% Gross Margin- 52W Low220.00% ATR0.06
Employees44 Current Ratio0.54 Sales Q/Q-184.70% Oper. Margin- RSI (14)52.10 Volatility11.09% 16.98%
OptionableNo Debt/Eq0.01 EPS Q/Q74.40% Profit Margin- Rel Volume4.17 Prev Close0.55
ShortableYes LT Debt/Eq0.01 EarningsMay 13 Payout- Avg Volume227.62K Price0.58
Recom1.70 SMA207.06% SMA50-11.25% SMA200-46.89% Volume271,473 Change4.73%
05-Dec-12Downgrade Northland Securities Outperform → Market Perform $1.40
06-Aug-12Initiated Ascendiant Capital Markets Buy $2
13-Jul-12Initiated Wunderlich Hold $1.75
14-May-12Downgrade Feltl & Co. Strong Buy → Buy $6.50 → $2.35
24-Feb-12Initiated Northland Securities Outperform $4
23-May-13 02:28PM  Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System PR Newswire +14.58%
09:52AM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements EDGAR Online
21-May-13 07:51AM  InPlay: Echo Therapeutics announces Institutional Review Board approval for its clinical trial of the Symphony CGM System Briefing.com
07:50AM  Echo Therapeutics Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System PR Newswire
17-May-13 01:04PM  ECHO THERAPEUTICS, INC. Financials EDGAR Online Financials
16-May-13 12:04PM  Dario Seeks To Capitalize On New Technology For Diabetic Test Strips at Seeking Alpha
07:50AM  Echo Therapeutics to Unveil Symphony® CGM System in Webcast PR Newswire
15-May-13 12:24PM  LabStyle Innovations - Glucose Monitoring For The Mobile Age at Seeking Alpha
10-May-13 09:32AM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online -5.66%
09:22AM  ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:50AM  Echo Therapeutics Announces First Quarter 2013 Financial Results PR Newswire
30-Apr-13 04:02PM  Hedge Fund Platinum Partners Favorite Stocks Might Surprise You at Motley Fool
29-Apr-13 04:04PM  Hedge Fund Platinum Partners Favorite Stocks Might Surprise You at Motley Fool
22-Mar-13 01:04PM  ECHO THERAPEUTICS, INC. Financials EDGAR Online Financials
09:32AM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Notice of Delisting or Fai EDGAR Online
18-Mar-13 07:50AM  Echo Therapeutics, Inc. Announces 2012 Financial Results PR Newswire
01:36AM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online
15-Mar-13 07:50AM  Echo Therapeutics Achieves ISO 13485 Certification PR Newswire
13-Mar-13 01:18PM  4 Healthcare Stock Stories for Wednesday Investment Wellness at Wall St. Cheat Sheet
07:50AM  Echo Therapeutics Appoints Robert Doman to Board of Directors PR Newswire
12-Mar-13 08:50AM  InPlay: Echo Therapeutics granted U.S. patent for Prelude SkinPrep System Briefing.com
07:50AM  Echo Therapeutics granted U.S. patent for Prelude SkinPrep System theflyonthewall.com
07:50AM  Echo Therapeutics Granted U.S. Patent for Prelude® SkinPrep System PR Newswire
06-Feb-13 12:00PM  Echo Therapeutics Announces Closing of Public Offering of Common Stock PR Newswire
04-Feb-13 06:02PM  Nasdaq stocks posting largest volume increases AP
05:27PM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01-Feb-13 07:19PM  4 Healthcare Stock Stories for TGIF Wellness at Wall St. Cheat Sheet -28.45%
06:02PM  Nasdaq stocks posting largest volume increases AP
04:04PM  Fridays biggest gaining and declining stocks at MarketWatch
03:01PM  Fridays biggest gaining and declining stocks at MarketWatch
01:23PM  Fridays biggest gaining and declining stocks at MarketWatch
10:42AM  Fridays biggest gaining and declining stocks at MarketWatch
09:27AM  Stocks to Watch: Tyson Foods, Audience, Life Time Fitness at The Wall Street Journal
09:26AM  Fridays biggest gaining and declining stocks at MarketWatch
06:11AM  Echo Therapeutics 13.33M share Spot Secondary priced at $.75 theflyonthewall.com
01:10AM  InPlay: Echo Therapeutics prices 13,333,333 shares of common stock at $0.75 Briefing.com
31-Jan-13 08:26PM  Echo Therapeutics Announces Pricing of Public Offering of Common Stock PR Newswire
04:09PM  InPlay: Echo Therapeutics announces proposed public offering; size not disclosed Briefing.com
04:05PM  Echo Therapeutics Announces Proposed Public Offering PR Newswire
23-Jan-13 04:00PM  4 Healthcare Stock Stories for Wednesday Wellness at Wall St. Cheat Sheet
22-Jan-13 07:55AM  InPlay: Echo Therapeutics presents positive clinical trial results of the Symphony tCGM system at the 42nd Critical Care Congress Briefing.com -6.72%
07:50AM  Echo Therapeutics Presents Positive Clinical Trial Results of the Symphony® tCGM System at the 42nd Critical Care Congress PR Newswire
15-Jan-13 07:50AM  Echo Therapeutics to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference PR Newswire
07-Jan-13 11:04AM  Echo Therapeutics seeking partnership deal, readying glucose monitoring system at bizjournals.com
07:53AM  InPlay: Echo Therapeutics issued the following corporate update to its shareholders; Echo completed two clinical trials of the Symphony tCGM System in critically ill patients Briefing.com
07:50AM  Echo Therapeutics, Inc. (Nasdaq: ECTE) Provides an Update to Shareholders PR Newswire
27-Dec-12 04:56PM  Echo Therapeutics hears chaching of closed stock sale at bizjournals.com
04:15PM  Echo Therapeutics Announces Closing of Public Offering of Common Stock PR Newswire
07:50AM  Echo Therapeutics to Present at Biotech Showcase 2013 in San Francisco PR Newswire
26-Dec-12 04:15PM  Echo Therapeutics Announces Full Exercise of Over-Allotment Option PR Newswire
22-Dec-12 11:42AM  Roche Might Buy Illumina, Echo Therapeutics Prices Public Offering: Healthcare Business Wrap at Wall St. Cheat Sheet
21-Dec-12 02:25PM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -17.39%
12:09PM  Political Disarray Hits Stocks at The Wall Street Journal
11:20AM  Political Disarray Hits Stocks at The Wall Street Journal
10:39AM  Political Disarray Hits Stocks at The Wall Street Journal
10:00AM  Political Disarray Hits Stocks at The Wall Street Journal
09:13AM  Stock Futures Slump on 'Cliff' Fears at The Wall Street Journal
08:57AM  Stock Futures Slump on 'Cliff' Fears at The Wall Street Journal
08:11AM  Stock Futures Slump on 'Cliff' Fears at The Wall Street Journal
20-Dec-12 08:22PM  Echo Therapeutics Announces Pricing of Public Offering of Common Stock PR Newswire
04:25PM  InPlay: Echo Therapeutics announces public offering of common stock, size not disclosed Briefing.com
04:24PM  Echo Therapeutics Announces Proposed Public Offering PR Newswire
12-Dec-12 07:50AM  Echo Therapeutics to Present Clinical Study Results of Symphony® tCGM System at the 42nd Critical Care Congress PR Newswire
04-Dec-12 10:23PM  Echo Therapeutics downgraded by Northland Securities Briefing.com
03-Dec-12 07:05AM  Echo Therapeutics: Speculative Stock With Significant Upside Potential at Seeking Alpha
29-Nov-12 11:44AM  Echo Therapeutics: Never mind about that stock offering at bizjournals.com
07:50AM  Echo Therapeutics to Present at the Canaccord Genuity 2012 Medical Technology & Diagnostics Forum PR Newswire
07:31AM  InPlay: Echo Therapeutics announces withdrawal of proposed follow-on offering due to market conditions Briefing.com
07:30AM  Echo Therapeutics Announces Withdrawal of Proposed Follow-On Offering PR Newswire
27-Nov-12 04:15PM  InPlay: Echo Therapeutics announces proposed public offering, size not disclosed Briefing.com
04:15PM  Echo Therapeutics Announces Proposed Public Offering PR Newswire
19-Nov-12 07:50AM  Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain PR Newswire
16-Nov-12 01:04PM  ECHO THERAPEUTICS, INC. Financials EDGAR Online Financials
10-Nov-12 09:29AM  New Star Analyst Rankings for Echo Therapeutics, Inc. StarMine
09-Nov-12 06:59PM  Echo Therapeutics's CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
12:11PM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
09:32AM  New Star Analyst Rankings for Echo Therapeutics, Inc. StarMine
07:50AM  Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting PR Newswire
08-Nov-12 04:20PM  ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:50AM  Echo Therapeutics Announces Third Quarter 2012 Financial Results PR Newswire
07-Sep-12 04:31PM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia EDGAR Online
04-Sep-12 07:50AM  Echo Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference PR Newswire
30-Aug-12 04:11PM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online
25-Aug-12 02:40AM  5 Healthcare Companies With Insider Buying Filed On August 22 - 23 at Seeking Alpha
17-Aug-12 01:04PM  ECHO THERAPEUTICS, INC. Financials EDGAR Online Financials
14-Aug-12 04:09PM  ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fin EDGAR Online
13-Aug-12 09:37AM  New Star Analyst Rankings for Echo Therapeutics, Inc. StarMine
12-Aug-12 09:35AM  New Star Analyst Rankings for Echo Therapeutics, Inc. StarMine
10-Aug-12 07:50AM  Echo Therapeutics Announces Second Quarter 2012 Financial Results PR Newswire
09-Aug-12 02:39PM  ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online +6.21%
08:09AM  InPlay: Echo Therapeutics announces $20 mln financing with Platinum-Montaur Life Sciences Briefing.com
08:00AM  Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences PR Newswire
07-Aug-12 10:31AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
06-Aug-12 10:29AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
10:12AM  Equity Briefing: Upgrades and Downgrades for August 6th: AGNC, AHT, AMTG, ARRS, AWK, AZSEY, BEAV, BMPI, BPO, B Thomson Reuters ONE
09:20AM  New Stock Coverage: Apollo Residential Going to Pluto? at Minyanville
05-Aug-12 09:16PM  Coverage initiated on Echo Therapeutics by Ascendiant Capital Markets Briefing.com
01-Aug-12 07:52AM  InPlay: Echo Therapeutics announces 'positive' clinical trial results of Symphony tCGM system Briefing.com +6.76%
07:50AM  Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® tCGM System PR Newswire
13-Jul-12 12:01PM  Equity Briefing: Stock Analysts' New Coverage for July 12th: CRM, FNSR, JDSU, PVH Thomson Reuters ONE
Echo Therapeutics, Inc. operates as a transdermal medical device company in the United States. The company is involved in developing Prelude SkinPrep System, which is a platform technology to allow painless skin permeation that would enable both needle-free drug delivery and analyte extraction; and Symphony tCGM System, a non-invasive, wireless, and transdermal continuous glucose monitoring system for use in hospital critical care units and for patients with diabetes. It also engages in the development of specialty pharmaceuticals based on its proprietary AzoneTS transdermal drug reformulation technology. The company's drug candidate is Durhalieve, an AzoneTS formulation of triamcinolone acetonide for the treatment of corticosteroid-responsive dermatoses. It has a licensing agreement with Ferndale Pharma Group, Inc. to develop, market, sell, and distribute Prelude for skin preparation prior to the application of topical anesthetics prior to a range of needle-based medical procedures in North America and the United Kingdom; and a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, market, sell, and distribute Symphony to medical facilities and diabetics in South Korea. Echo Therapeutics, Inc. was founded in 1989 and is headquartered in Philadelphia, Pennsylvania.